CNBC · General

India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top

· By Priyanka Salve, Elsa Ohlen
Story summary

The first wave of generic versions of Novo Nordisk's GLP-1 weight-loss drugs launched in India over the weekend, with at least five domestic drugmakers undercutting the original price by up to 80%. It comes as the Danish drugmaker's patent expired on Friday, with the company fighting to maintain its lead in the lucr…

Read at CNBC

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.